NCT05491733View on ClinicalTrials.gov

A Bioequivalence Study of APX001 High-load and Low-load Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 2, 2021

Primary Completion Date

May 13, 2021

Study Completion Date

June 23, 2021

Conditions
Invasive Fungal Infections
Interventions
DRUG

APX001

Low-load oral tablet

DRUG

APX001A

High-load oral tablet

Trial Locations (1)

84124

Pharmaceuticals Research Associates, Inc, Salt Lake City

Sponsors
All Listed Sponsors
lead

Basilea Pharmaceutica

INDUSTRY